ATE50768T1 - 2,5-diaryltetrahydrofurane und analoge davon als antagonisten fuer thrombozyten aktivierenden faktor. - Google Patents

2,5-diaryltetrahydrofurane und analoge davon als antagonisten fuer thrombozyten aktivierenden faktor.

Info

Publication number
ATE50768T1
ATE50768T1 AT84113600T AT84113600T ATE50768T1 AT E50768 T1 ATE50768 T1 AT E50768T1 AT 84113600 T AT84113600 T AT 84113600T AT 84113600 T AT84113600 T AT 84113600T AT E50768 T1 ATE50768 T1 AT E50768T1
Authority
AT
Austria
Prior art keywords
substituted
activating factor
cor
chem
pyrryl
Prior art date
Application number
AT84113600T
Other languages
English (en)
Inventor
Tesfaye Biftu
San-Bao Hwang
Thomas W Doebber
Thomas R Beattie
Tsung-Ying Shen
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE50768T1 publication Critical patent/ATE50768T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
AT84113600T 1983-11-14 1984-11-12 2,5-diaryltetrahydrofurane und analoge davon als antagonisten fuer thrombozyten aktivierenden faktor. ATE50768T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/551,666 US4539332A (en) 1983-11-14 1983-11-14 2,5-Diaryl tetrahydrofurans and analogs thereof as PAF-antagonists
EP84113600A EP0144804B1 (de) 1983-11-14 1984-11-12 2,5-Diaryltetrahydrofurane und Analoge davon als Antagonisten für Thrombozyten aktivierenden Faktor

Publications (1)

Publication Number Publication Date
ATE50768T1 true ATE50768T1 (de) 1990-03-15

Family

ID=24202197

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84113600T ATE50768T1 (de) 1983-11-14 1984-11-12 2,5-diaryltetrahydrofurane und analoge davon als antagonisten fuer thrombozyten aktivierenden faktor.

Country Status (8)

Country Link
US (1) US4539332A (de)
EP (1) EP0144804B1 (de)
JP (1) JPS60116679A (de)
AT (1) ATE50768T1 (de)
CA (1) CA1267417A (de)
DE (1) DE3481511D1 (de)
DK (1) DK538384A (de)
ES (1) ES8606318A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619943A (en) * 1981-06-04 1986-10-28 Rao Koppaka V Neolignans of Saururus cernuus L and analogues thereof
US5010100A (en) * 1983-11-14 1991-04-23 Merck & Co. Inc. Certain 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
JPS61212518A (ja) * 1985-03-19 1986-09-20 Nippon Paint Co Ltd 血液凝固促進剤
NZ215866A (en) * 1985-04-22 1989-11-28 Merck & Co Inc 2,5-di(aryl/heterocyclyl) tetrahydro-furans and pharmaceutical compositions
DE3778248D1 (de) * 1986-08-21 1992-05-21 Merck & Co Inc 1,3-diarylcyclopentane und deren abkoemmlinge als paf-antagonisten.
US4879285A (en) * 1986-08-22 1989-11-07 Royal North Shore Hospital And Area Health Service Fertility control
PH23898A (en) * 1986-09-12 1989-12-18 Duphar Int Res New phenyl pyrrolidin-2-yl substituted-2-yl substituted 5-ring heterocycles having antipsycotic properties
GB2197650A (en) * 1986-11-21 1988-05-25 Merck & Co Inc Process for preparing 2,5-diphenyl tetrahydrofurans and analogs thereof
US4996203A (en) * 1987-12-21 1991-02-26 Merck & Co., Inc. 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
NZ227287A (en) * 1987-12-21 1992-01-29 Merck & Co Inc 2,5-diaryl tetrahydrofurans and medicaments
ES2044100T4 (es) * 1988-04-27 1996-07-16 Schering Corp Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
US5334592A (en) * 1988-04-27 1994-08-02 Schering Corporation Certain PAF antagonist antihistamine combinations and methods
ES2010568A6 (es) * 1988-08-04 1989-11-16 Uriach & Cia Sa J Procedimiento para la obtencion de derivados 2,5-disustituidos de tetrahidrofurano.
GB8904174D0 (en) * 1989-02-23 1989-04-05 British Bio Technology Compounds
US5001123A (en) * 1989-06-08 1991-03-19 Merck & Co., Inc. 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
US5114961A (en) * 1989-06-08 1992-05-19 Merck & Co., Inc. 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
US5011847A (en) * 1989-06-08 1991-04-30 Merck & Co., Inc. 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
US4977146A (en) * 1989-06-08 1990-12-11 Merck & Co., Inc. 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
DE4014420A1 (de) * 1989-09-23 1991-04-04 Bayer Ag 5h-furan-2-on-derivate
GB9009469D0 (en) * 1990-04-27 1990-06-20 British Bio Technology Compounds
US5099033A (en) * 1990-06-29 1992-03-24 Merck & Co., Inc. Process of making 2,5-diaryl tetrahydrofurans and analogs thereof useful as PAF antagonists
US5274094A (en) * 1990-08-15 1993-12-28 British Bio-Technology Limited Production of heterobicyclic containing benzene sulfonamides
IE912874A1 (en) * 1990-08-15 1992-02-26 British Bio Technology Compounds
ATE205084T1 (de) * 1991-03-04 2001-09-15 Ct For Innovative Technology 2,4-diaryl-1,3-dithiolane als platelet activating faktor rezeptorblocker und 5-lipoxygenasehemmer
GB9104746D0 (en) * 1991-03-06 1991-04-17 British Bio Technology Compounds
GB9114337D0 (en) * 1991-07-03 1991-08-21 British Bio Technology Compounds
GB9116056D0 (en) * 1991-07-24 1991-09-11 British Bio Technology Compounds
GB9122308D0 (en) * 1991-10-21 1991-12-04 British Bio Technology Compounds
GB9200209D0 (en) * 1992-01-07 1992-02-26 British Bio Technology Compounds
US5530141A (en) * 1992-03-04 1996-06-25 Center For Innovative Technology 2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1,3-oxathiolanes; and 2,5-diaryl-1,3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5639782A (en) * 1992-03-04 1997-06-17 Center For Innovative Technology Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors
US5463083A (en) * 1992-07-13 1995-10-31 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5648486A (en) * 1992-07-13 1997-07-15 Cytomed, Inc. Compounds and methods for the treatment of inflammatory and immune disorders
US5434151A (en) * 1992-08-24 1995-07-18 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5358938A (en) * 1992-07-13 1994-10-25 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
CA2140034A1 (en) 1992-07-13 1994-01-20 Xiong Cai 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders
US5629340A (en) * 1993-01-11 1997-05-13 Tsumura & Co. Angiogenesis inhibitor and novel compound
US6492413B2 (en) 1993-01-15 2002-12-10 G.D. Searle & Co. 3.4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5703093A (en) * 1995-05-31 1997-12-30 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5792776A (en) * 1994-06-27 1998-08-11 Cytomed, Inc., Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5750565A (en) * 1995-05-25 1998-05-12 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
WO2022144843A1 (en) 2020-12-30 2022-07-07 3M Innovative Properties Company Bondable orthodontic assemblies and methods for bonding

Also Published As

Publication number Publication date
ES537583A0 (es) 1986-04-16
JPS60116679A (ja) 1985-06-24
EP0144804A2 (de) 1985-06-19
EP0144804A3 (en) 1986-01-08
DK538384A (da) 1985-06-19
JPH0550516B2 (de) 1993-07-29
ES8606318A1 (es) 1986-04-16
EP0144804B1 (de) 1990-03-07
US4539332A (en) 1985-09-03
DK538384D0 (da) 1984-11-13
CA1267417A (en) 1990-04-03
DE3481511D1 (de) 1990-04-12

Similar Documents

Publication Publication Date Title
ATE50768T1 (de) 2,5-diaryltetrahydrofurane und analoge davon als antagonisten fuer thrombozyten aktivierenden faktor.
ZA844585B (en) 2-pyrimidinyl-1-piperazine derivatives,processes for their preparation and medicaments containing them
ES2002312A6 (es) Procedimiento para la preparacion de nuevos 2,5-doaril-tetrahiodrotiofenos y analogos de los mismos, utiles ccomo antagonistas del fap.
DK0482208T3 (da) Pyridazinonderivat
ES8307806A1 (es) "procedimiento para la preparacion de 1,2-a piridinas y pirazinas".
ES8600060A1 (es) Procedimiento para preparar un medicamento envasado que contiene como sustancia activa un antagonista del calcio tal como nifedipina, verapamil diltiazem y otros.
ES453947A1 (es) Un procedimiento para la preparacion de nuevas imidazo (1,2-alfa) piridinas sustituidas.
EP0322033A3 (de) 2,5-Diaryl tetrahydrofurane und Analoge als PAF-Antagonisten
ES8200094A1 (es) Procedimiento para la obtencion de alquilureas
IT1238684B (it) Derivati del bilobalide,loro usi e formulazioni che li contegono
IL64472A0 (en) Pharmaceutical compositions containing tricyclic cytosin derivatives,certain new compounds of this class and their production
ES8306483A1 (es) Procedimiento de preparacion de las dibezooxepinas sustituidas y de sus sales de adicion con un acido mineral u organico
FI844232A0 (fi) Purinderivat.
ES8705439A1 (es) Procedimiento para preparar derivados de pirazol-(1,5-a)piridina
IT7950049A0 (it) Derivati acetilenici dell'androst-4-ene,procedimento per la loro produzione,loro impiego come medicamenti e composizioni farmaceutiche che licontengono
DK165100C (da) Phosphatidholdigt, fungicidt praeparat, dets fremstilling og anvendelse
IT1221914B (it) Derivati dell'acido carbazico,procedimento per la loro preparazione e composizioni che ne contengono
IT8024152A0 (it) Derivati dell'1,1,2-trifenilpropano e dell'1,1,2-trifenilpropene, procedimento per la loro preparazione e composizioni farmaceutiche contenenti i composti
IT1241927B (it) 3'-deamino-4'-deossi-4'-amino-8-fluoroantra- cicline processi per la loro preparazione e composizioni farmaceutiche che le contengono
CA159452A (en) Child's pants
IT8019354A0 (it) Derivati dell'acido nicotinico adattivita' terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT8321358A1 (it) Derivati ad attività terapeutica della S-carbossimetilcisteina, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee